Your browser doesn't support javascript.
loading
A comprehension of signaling pathways and drug resistance; an insight into the correlation between microRNAs and cancer.
Alsaab, Hashem O; Abdullaev, Bekhzod; Alkhafaji, Adnan Taan; Alawadi, Ahmed Hussien; Jahlan, Ibtesam; Bahir, Hala; Bisht, Yashwant Singh; Alsaalamy, Ali; Jabbar, Abeer Mhussan; Mustafa, Yasser Fakri.
Afiliación
  • Alsaab HO; Department of Pharmaceutics and Pharmaceutical Technology, Taif University, Taif 21944, Saudi Arabia. Electronic address: hashemalsaab@gmail.com.
  • Abdullaev B; Research Department of Biotechnology, New Uzbekistan University, Mustaqillik Avenue 54, Tashkent 100007, Uzbekistan; Department of Oncology, School of Medicine, Central Asian University, Milliy Bog Street 264, Tashkent 111221, Uzbekistan. Electronic address: author.uzb@mail.ru.
  • Alkhafaji AT; Cardiology Department, College of Medicine, Al-Ayen University, Dhi-Qar, Iraq.
  • Alawadi AH; College of Technical Engineering, the Islamic University, Najaf, Iraq; College of Technical Engineering, the Islamic University of Al Diwaniyah, Iraq; College of Technical Engineering, the Islamic University of Babylon, Iraq.
  • Jahlan I; Maternal and Child Health Nursing Department, King Saud University, Riyadh, Saudi Arabia.
  • Bahir H; Medical Technical College, Al-Farahidi University, Baghdad, Iraq.
  • Bisht YS; Department of Mechanical Engineering, Uttaranchal Institute of Technology, Uttaranchal University, Dehradun 248007, India.
  • Alsaalamy A; College of Technical Engineering, Imam Ja'afar Al-Sadiq University, Al-Muthanna 66002, Iraq.
  • Jabbar AM; College of Pharmacy, National University of Science and Technology, Dhi Qar, Iraq.
  • Mustafa YF; Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul 41001, Iraq.
Pathol Res Pract ; 251: 154848, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37862919
ABSTRACT
Despite the development of numerous therapies, cancer remains an incurable disease due to various factors, including drug resistance produced by cancer cells. MicroRNAs (miRNAs) regulate different target genes involved in biological and pathological processes, including cancer, through post-transcriptional mechanisms. The development of drug resistance in cancer treatment is a significant barrier because it decreases drug uptake, cellular transport, and changes in proteins involved in cell proliferation, survival, and apoptotic pathways. Numerous studies have found a connection between miRNAs and the development of drug resistance in cancer cells. This paper provides a broad overview of how miRNAs regulate signaling pathways and influence treatment resistance in different cancers.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs / Neoplasias Límite: Humans Idioma: En Revista: Pathol Res Pract Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs / Neoplasias Límite: Humans Idioma: En Revista: Pathol Res Pract Año: 2023 Tipo del documento: Article